IA
ZSAN

IFP Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

IFP Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$6K Buy
+36
New +$4.41K ﹤0.01% 1822
2016
Q2 		– Sell
-2
Closed -$6K – 4147
2016
Q1 		$6K Buy
+2
New +$3.29K ﹤0.01% 1814

Other funds holding ZSAN

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors's ZSAN Position: Q1 2019 in Review

IFP Advisors opened a new position in Zosano Pharma Corporation (ZSAN) in Q1 2019: 36 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #1822 among its holdings. This is a return to the name: IFP Advisors previously reported a position in ZSAN as recently as Q1 2016.

IFP Advisors first reported a position in ZSAN in Q1 2016 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold ZSAN as of Q1 2019.

  • IFP Advisors held 36 shares of Zosano Pharma Corporation worth $6K as of Q1 2019.
  • Zosano Pharma Corporation was a new IFP Advisors position in Q1 2019.
  • Zosano Pharma Corporation made up ﹤0.01% of IFP Advisors's portfolio in Q1 2019, its #1822 holding.
  • IFP Advisors first reported a position in Zosano Pharma Corporation in Q1 2016 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.